These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1676275)

  • 1. Neutralizing and complement-dependent enhancing antibodies in different stages of HIV infection.
    Tóth FD; Szabó B; Ujhelyi E; Pálóczi K; Horváth A; Füst G; Kiss J; Bánhegyi D; Hollán SR
    AIDS; 1991 Mar; 5(3):263-8. PubMed ID: 1676275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizing and enhancing antibodies measured in complement-restored serum samples from HIV-1-infected individuals correlate with immunosuppression and disease.
    Füst G; Tóth FD; Kiss J; Ujhelyi E; Nagy I; Bánhegyi D
    AIDS; 1994 May; 8(5):603-9. PubMed ID: 7914732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of a clinical correlation for complement-mediated, infection-enhancing antibodies in plasma or sera from HIV-1-infected individuals. Multicenter AIDS Cohort Study Group.
    Montefiori DC; Lefkowitz LB; Keller RE; Holmberg V; Sandstrom E; Phair JP
    AIDS; 1991 May; 5(5):513-7. PubMed ID: 1863402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion.
    Boyer V; Desgranges C; Trabaud MA; Fischer E; Kazatchkine MD
    J Exp Med; 1991 May; 173(5):1151-8. PubMed ID: 1827139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing antibodies and serum interferon levels in the different stages of HIV infection.
    Szabó B; Tóth FD; Kiss J; Ujhelyi E; Füst G; Horváth A; Hollán SR
    Acta Virol; 1990 Apr; 34(2):164-70. PubMed ID: 1975977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of antibodies that are associated with disease progression in HIV disease.
    Tóth FD; Süsal C; Ujhelyi E; Bánhegyi D; Kiss J; Daniel V; Nagy I; Opelz G; Füst G
    Immunol Lett; 1994 Jun; 41(1):33-6. PubMed ID: 7959901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 neutralizing antibodies in urine from seropositive individuals.
    Cao YZ; Friedman-Kien AE; Mirabile M; Li XL; Alam M; Dieterich D; Ho DD
    J Acquir Immune Defic Syndr (1988); 1990; 3(3):195-9. PubMed ID: 1968094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of serum antibodies to a conformational epitope of HIV-1/gp120 identified by a human monoclonal antibody is associated with disease progression.
    Cavacini LA; Emes CL; Power J; Underdahl J; Goldstein R; Mayer K; Posner MR
    J Acquir Immune Defic Syndr (1988); 1993 Oct; 6(10):1093-102. PubMed ID: 7692037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing antibodies in relation to antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus type I.
    Böttiger B; Ljunggren K; Karlsson A; Krohn K; Fenyö EM; Jondal M; Biberfeld G
    Clin Exp Immunol; 1988 Sep; 73(3):339-42. PubMed ID: 3208445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus neutralizing antibodies at different stages of the HIV disease: increased levels after azidothymidine treatment.
    Schmidtmayerová H; Lackovicová M; Stanková M; Brůcková M; Surový I; Ujhelyi E; Füst G; Mayer V
    Acta Virol; 1992 Mar; 36(2):157-65. PubMed ID: 1359767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased adhesion as a mechanism of antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus infection.
    Lund O; Hansen J; Søorensen AM; Mosekilde E; Nielsen JO; Hansen JE
    J Virol; 1995 Apr; 69(4):2393-400. PubMed ID: 7884885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection.
    Willey S; Aasa-Chapman MM; O'Farrell S; Pellegrino P; Williams I; Weiss RA; Neil SJ
    Retrovirology; 2011 Mar; 8():16. PubMed ID: 21401915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement-mediated antibody-dependent enhancement of HIV-1 infection requires CD4 and complement receptors.
    Robinson WE; Montefiori DC; Mitchell WM
    Virology; 1990 Apr; 175(2):600-4. PubMed ID: 2327077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement-mediated, antibody-dependent neutralizing titers of sera from asymptomatic and symptomatic HIV-infected individuals.
    Spear GT; Carlson JR; Jennings MB; Takefman DM; Landay AL
    AIDS; 1992 Sep; 6(9):1047. PubMed ID: 1388899
    [No Abstract]   [Full Text] [Related]  

  • 15. Complement-activating antibodies in sera from infected individuals and vaccinated volunteers that target human immunodeficiency virus type 1 to complement receptor type 1 (CR1, CD35).
    Zhou J; Montefiori DC
    Virology; 1996 Dec; 226(1):13-21. PubMed ID: 8941318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of isolate-specific neutralizing activity is correlated with an increased viral burden in rapidly progressing HIV-1-infected patients.
    Lu W; Shih JW; Tourani JM; Eme D; Alter HJ; Andrieu JM
    AIDS; 1993 Nov; 7 Suppl 2():S91-9. PubMed ID: 7909232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant decrease of the enhancement/neutralization index in HIV patients during highly active antiretroviral therapy (HAART).
    Bánhegyi D; Bácsi A; Tóth FD; Prohászka Z; Horváth A; Beck Z; Kónya J; Füst G
    Immunol Lett; 2003 Oct; 89(1):25-30. PubMed ID: 12946861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis of CD4+ and CD19+ cells during human immunodeficiency virus type 1 infection--correlation with clinical progression, viral load, and loss of humoral immunity.
    Samuelsson A; Broström C; van Dijk N; Sönnerborg A; Chiodi F
    Virology; 1997 Nov; 238(2):180-8. PubMed ID: 9400591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and specificity of lymphocytotoxic antibodies in different stages of HIV infection.
    Szabó B; Tóth FD; Kiss J; Füst G; Ujhelyi E; Bánhegyi D; Horváth A; Hollán SR
    Acta Virol; 1992 Aug; 36(4):392-400. PubMed ID: 1362323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the serologic profile of children with human immunodeficiency virus infection: correlation with clinical status.
    Kamani N; Krilov LR; Wittek AE; Hendry RM
    Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 1):233-42. PubMed ID: 2791340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.